Glucose metabolism abnormalities, particularly diabetes, enhance liver fibrosis risk through oxidative stress pathway activation and chronic inflammatory response promotion, while disrupting hepatic gluconeogenesis and insulin metabolism (37). The gene discussed is INS; the disease is diabetes mellitus.